For instance, Fossaluza et al. assessed the clinical differences of patients with primary Sjögren’s syndrome based on either ANA and/or anti-ENA antibody-negative or -positive cases, therefore excluding the non-identified ANA-positive subgroup [11]. The gene discussed is BTG3; the disease is Sjogren syndrome.